Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01783431 · ClinicalTrials.gov registry record · Phase 1
Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells
A Phase 1 study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01783431: Clinical Trial Phase 1 study, sponsored by Medical University of South Carolina.
NCT01783431 is a Phase 1 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01783431, a Phase 1 study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is for subjects with a type of skin cancer called melanoma. The main purpose of this study is to examine the safety of the study drug (Poly-ICLC) in patients with your disease. The study team would like to know about any side effects a patient may have when given the study drug. Another goal of the study is to determine if combining dendritic cells and the study drug can be possibly used as a vaccine for your disease.
Primary Outcome
\- safety of this treatment by evaluating the qualitative and quantitative toxicities in this group of patients through adverse event reporting
Interventions
- DRUG Poly ICLC
- PROCEDURE leukapheresis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
Why NCT01783431 stopped before completion
NCT01783431 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Poly ICLC is the first listed.
NCT01783431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01783431 about?
NCT01783431 is a clinical study titled "Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells". This study is for subjects with a type of skin cancer called melanoma. The main purpose of this study is to examine the safety of the study drug (Poly-ICLC) in patients with your disease. The study team would like to know about any side effects a patient may have when given the study drug. Another g...
What is the current status of trial NCT01783431?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2012-10. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01783431?
The interventions under investigation include: Poly ICLC (DRUG), leukapheresis (PROCEDURE).
Who is sponsoring clinical trial NCT01783431?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01783431's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia